You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ovarian cancer, pembrolizumab, olaparib

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Ovarian Epithelial Trial in Hidaka (pembrolizumab, olaparib, bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • pembrolizumab
  • +5 more
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
Apr 25, 2022

Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer Trial in Seoul (Olaparib-Pembrolizumab-Bevacizumab)

Enrolling by invitation
  • Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer
  • Seoul, Korea, Republic of
    Yonsei Severance Hospital
Apr 14, 2021

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

Not yet recruiting
  • Ovarian Cancer
  • Olaparib tablet
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Nov 1, 2023

Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

Not yet recruiting
  • Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Oct 30, 2023

Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt

Not yet recruiting
  • Advanced Ovarian Cancer
  • None (Observational Study)
  • (no location specified)
Mar 8, 2023

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
Jan 4, 2023

Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Feb 1, 2023

Prostate Cancer Trial in Lexington (biological, drug, radiation)

Not yet recruiting
  • Prostate Cancer
  • Pembrolizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Oct 3, 2022

Cervical Cancer Trial in Hidaka (Pembrolizumab, Olaparib)

Active, not recruiting
  • Cervical Cancer
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
Aug 8, 2022

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

Completed
  • Advanced Ovarian Cancer
  • Sabadell, Barcelona, Spain
  • +7 more
Jan 25, 2023

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

First-line Olaparib Combined With Bevacizumab Maintenance

Not yet recruiting
  • Ovarian Neoplasms
  • olaparib plus bevacizumab maintenance therapy
  • (no location specified)
Jun 29, 2022

Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

Completed
  • Ovarian Cancer
  • Breast Cancer
  • Ahmedabad, India
  • +15 more
Oct 28, 2022

Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor Trial

Active, not recruiting
  • Fallopian Tube Endometrioid Tumor
  • +13 more
  • Orange, California
  • +19 more
Jan 10, 2023

Nasopharyngeal Carcinoma Trial in Brescia (Pembrolizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Mar 29, 2022

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Ovarian Cancer, Breast Cancer Trial in Vijayawada (Olaparib tablets, 150 mg, Lynparza® (olaparib) tablets 150 mg)

Recruiting
  • Ovarian Cancer
  • Breast Cancer
  • Olaparib tablets, 150 mg
  • Lynparza® (olaparib) tablets 150 mg
  • Vijayawada, Andhra Pradesh, India
    Sandoz Investigative Site
Apr 12, 2022

Advanced Gastric Adenocarcinoma Trial in Baltimore (Paclitaxel, Olaparib, Pembrolizumab)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023